title: Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform.
abstract: Enhancement of the fluorescent output of surface-based fluorescence assays by performing them upon nanostructured photonic crystal (PC) surfaces has been demonstrated to increase signal intensities by >8000×. Using the multiplicative effects of optical resonant coupling to the PC in increasing the electric field intensity experienced by fluorescent labels ("enhanced excitation") and the spatially biased funneling of fluorophore emissions through coupling to PC resonances ("enhanced extraction"), PC enhanced fluorescence (PCEF) can be adapted to reduce the limits of detection of disease biomarker assays, and to reduce the size and cost of high sensitivity detection instrumentation. In this work, we demonstrate the first silicon-based PCEF detection platform for multiplexed biomarker assay. The sensor in this platform is a silicon-based PC structure, comprised of a SiO2 grating that is overcoated with a thin film of high refractive index TiO2 and is produced in a semiconductor foundry for low cost, uniform, and reproducible manufacturing. The compact detection instrument that completes this platform was designed to efficiently couple fluorescence excitation from a semiconductor laser to the resonant optical modes of the PC, resulting in elevated electric field strength that is highly concentrated within the region <100 nm from the PC surface. This instrument utilizes a cylindrically focused line to scan a microarray in <1 min. To demonstrate the capabilities of this sensor-detector platform, microspot fluorescent sandwich immunoassays using secondary antibodies labeled with Cy5 for two cancer biomarkers (TNF-α and IL-3) were performed. Biomarkers were detected at concentrations as low as 0.1 pM. In a fluorescent microarray for detection of a breast cancer miRNA biomarker miR-21, the miRNA was detectable at a concentration of 0.6 pM.
authors: Department of Bioengineering, 1304 West Springfield Avenue, University of Illinois, Urbana-Champaign, Illinois, 61801, USA. bcunning@illinois.edu.
authors: Sherine
authors: S
authors: George
authors: Vikram
authors: V
authors: Chaudhery
authors: Meng
authors: M
authors: Lu
authors: Miki
authors: M
authors: Takagi
authors: Nabil
authors: N
authors: Amro
authors: Anusha
authors: A
authors: Pokhriyal
authors: Yafang
authors: Y
authors: Tan
authors: Placid
authors: P
authors: Ferreira
authors: Brian T
authors: BT
authors: Cunningham
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D007118:Immunoassay / Q000295:instrumentation / Q000379:methods*; D007377:Interleukin-3 / Q000032:analysis; D007834:Lasers; D035683:MicroRNAs / Q000032:analysis*; D046228:Microarray Analysis; D055620:Optical Phenomena; D017785:Photons; D011506:Proteins / Q000032:analysis*; D012825:Silicon; D013050:Spectrometry, Fluorescence; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D007377:Interleukin-3; D035683:MicroRNAs; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; D012825:Silicon
references: FASEB J. 2006 Mar;20(3):419-25
references: 16507759
references: Nat Clin Pract Oncol. 2008 Oct;5(10):588-99
references: 18695711
references: ACS Nano. 2012 Jul 24;6(7):6150-64
references: 22695179
references: Nat Nanotechnol. 2007 Mar;2(3):145-55
references: 18654244
references: Ann N Y Acad Sci. 2004 Jun;1022:9-16
references: 15251933
references: Nat Genet. 2000 Nov;26(3):283-9
references: 11062466
references: Anal Chem. 2010 Apr 15;82(8):3118-23
references: 20192182
references: Eur J Cancer. 2007 Nov;43(17):2457-66
references: 17904355
references: Opt Lett. 2012 Jul 1;37(13):2565-7
references: 22743456
references: Nat Rev Cancer. 2008 Apr;8(4):268-78
references: 18337732
references: Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:133-9
references: 14656269
references: Nat Biotechnol. 2005 Oct;23(10):1294-301
references: 16170313
references: Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2273-6
references: 15695586
references: Clin Chem. 2002 Aug;48(8):1296-304
references: 12142387
references: Opt Express. 2009 Jul 20;17(15):13222-35
references: 19654728
references: Nano Lett. 2008 Dec;8(12):4210-6
references: 19367962
references: Nat Mater. 2007 Oct;6(10):782-9
references: 17676047
references: CA Cancer J Clin. 2008 May-Jun;58(3):161-79
references: 18443206
references: Am J Pathol. 2006 Jan;168(1):93-103
references: 16400012
references: Analyst. 2010 Oct;135(10):2496-511
references: 20614087
references: Science. 1999 Oct 15;286(5439):523-5
references: 10521346
references: Proteomics. 2006 Jul;6(14):4100-5
references: 16786488
references: Oncogene. 2007 Apr 26;26(19):2799-803
references: 17072344
references: Nat Clin Pract Oncol. 2006 Aug;3(8):448-57
references: 16894390
references: Nature. 2008 Apr 3;452(7187):571-9
references: 18385731
references: Angew Chem Int Ed Engl. 2003 Feb 3;42(5):494-500
references: 12569479
references: Cancer Biomark. 2010;6(3-4):211-9
references: 20660966
references: Cell. 2005 Jul 15;122(1):6-7
references: 16009126
references: Mol Diagn Ther. 2006;10(4):221-30
references: 16884325
references: Opt Express. 2010 Feb 15;18(4):3693-9
references: 20389379
references: Anal Chem. 2010 Oct 15;82(20):8551-7
references: 20857905
references: J Proteome Res. 2004 Mar-Apr;3(2):179-96
references: 15113093
references: Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2263-4
references: 15703290
references: Expert Rev Proteomics. 2006 Feb;3(1):37-44
references: 16445349
references: J Proteome Res. 2006 Jan;5(1):19-25
references: 16396491
references: Opt Express. 2010 Nov 22;18(24):24793-808
references: 21164826
references: Clin Chem. 2006 Aug;52(8):1528-38
references: 16777915
references: CMAJ. 2006 Sep 12;175(6):611-7
references: 16966666
references: Cancer Res. 2006 Mar 15;66(6):2953-61
references: 16540643